Apr. 23 at 4:55 PM
$BMEA $MLTX
Did anyone else invest in AMBRX back in 2022.
In early Dec 2022, AMBRX dropped to
$0.41. Delisting was around the corner. I told everyone I knew to buy AMBRX. Few listened. Bears and shorts were scalping, shorting & joking about how it was being delisted. I told people to buy! Retail gave up.
On Friday Dec 9, 2022. AMBRX released preliminary Phase 2 breast cancer data on ARX788. The data showed a 100% disease control rate. The stock went from
$0.41 to
$4.54 that day. A 1000% gain.
Many sold immediately. I said BUY MORE! Few did.
After falling back in Jan/2023 to around
$2. I told people to BUY EVEN MORE!
By June/2023 the price climbed to
$16. I told folks to buy or at least hold because J&J were stalking the company. NO ONE LISTENED.
6 months later, Jan 8, 2024; J&J bought AMBRX for
$28/share. From
$0.41 to
$28 in 13 months.
One day you'll wake up and realize your life has just changed because you bought
$BMEA &
$MLTX
These both have incredible journeys ahead.
